调节性T细胞在慢性阻塞性肺病中的作用
Meghashree Sampath1, Geetanjali Bade1, Randeep Guleria2
1Department of Physiology, AIIMS, New Delhi, India.
Pulmonary medicine
|April 14, 2025
概括
调节性T细胞 (Tregs) 在慢性阻塞性肺病 (COPD) 患者中显示抑制功能受损. 这种受损的Treg功能可能会导致COPD进展背后的炎症过程.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性炎症性肺部疾病,呼吸道阻塞的可逆性较差.
- 促炎和抗炎因素之间的不平衡与COPD的发病因子有关.
- 调节性T细胞 (Tregs) 是免疫反应的关键负面调节者,在控制炎症疾病方面至关重要.
研究的目的:
- 评估COPD患者中循环Tregs的抑制功能.
- 调查原始CD4+T细胞在COPD中产生诱导Tregs (iTregs) 的能力.
主要方法:
- 从20名COPD患者 (吸烟者和戒烟者) 和20名健康对照人群中分离了周围血液单核细胞.
- 通过在Treg共同培养下测量T响应细胞增殖来评估Treg抑制功能.
- 通过使用特定的细胞因子 (IL-2,TGF-β1) 和抗CD3刺激,从天真的CD4+T细胞诱导iTreg生成.
主要成果:
- 与对照组相比,Treg介导的T响应细胞抑制在COPD吸烟者和改造的吸烟者中显著减少.
- 细胞因子分析显示,COPD患者的IL-2,IL-10和TGF-β1水平降低.
- 在活跃的COPD吸烟者中观察到具有特定表型 (CD4+CD25+CD45RA+CD127-) 的iTregs的更高频率.
结论:
- 循环Tregs在COPD患者中表现出受损的抑制功能.
- 损坏的Treg功能,以及系统性炎症的增加,表明COPD在病变发生过程中起着重要作用.
- 这些发现凸显了Tregs作为治疗COPD的潜在治疗点.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:24T Cell Types and Functions
633
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
633
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K